209 related articles for article (PubMed ID: 15033093)
1. [Do we spend too much on medications? Pharmaceutical expenditures, an absolutely essential item in European countries].
Simó Miñan J; de Pablo González R; Ramos Maestre MJ; Gaztambide Ganuza MS
Aten Primaria; 2004 Mar; 33(5):244-53. PubMed ID: 15033093
[TBL] [Abstract][Full Text] [Related]
2. [Health care expenditure in Spain compared with developed Europe, 1985-2001. The Spanish primary health care, the European Cinderella].
Simó Miñana J; Gérvas Camacho J; Seguí Díaz M; Pablo González Rd; Domínguez Velázquez J
Aten Primaria; 2004 Nov; 34(9):472-81. PubMed ID: 15563785
[TBL] [Abstract][Full Text] [Related]
3. Spending on medicines in Israel in an international context.
Sax P
Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
[TBL] [Abstract][Full Text] [Related]
4. HEALTH CARE EXPENDITURES OF 179 COUNTRIES WITH DIFFERENT GNI PER CAPITA IN 2018.
Vezhnovets TA; Gurianov VG; Prus NV; Korotkyi OV; Antonyuk OY
Wiad Lek; 2021; 74(3 cz 2):678-683. PubMed ID: 33843634
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two-step instrumental variables strategy.
Shaikh M; Gandjour A
Health Econ; 2019 Jan; 28(1):101-122. PubMed ID: 30306669
[TBL] [Abstract][Full Text] [Related]
6. ANALYSIS OF TRENDS IN LIFE EXPECTANCIES AND PER CAPITA GROSS DOMESTIC PRODUCT AS WELL AS PHARMACEUTICAL AND NON-PHARMACEUTICAL HEALTHCARE EXPENDITURES.
Hermanowski T; Bystrov V; Staszewska-Bystrova A; Szafraniec-Buryło SI; Rabczenko D; Kolasa K; Orlewska E
Acta Pol Pharm; 2015; 72(5):1045-50. PubMed ID: 26665412
[TBL] [Abstract][Full Text] [Related]
7. Labelled drug-related public expenditure in relation to gross domestic product (GDP) in Europe: a luxury good?
Prieto L
Subst Abuse Treat Prev Policy; 2010 May; 5():9. PubMed ID: 20478069
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical expenditure compared across countries.
van Mosseveld C
Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959
[TBL] [Abstract][Full Text] [Related]
9. The relationship between health expenditure indicators and economic growth in OECD countries: A Driscoll-Kraay approach.
Beylik U; Cirakli U; Cetin M; Ecevit E; Senol O
Front Public Health; 2022; 10():1050550. PubMed ID: 36478719
[TBL] [Abstract][Full Text] [Related]
10. International health care spending.
Schieber GJ; Puollier JP
Health Aff (Millwood); 1986; 5(3):111-22. PubMed ID: 3098657
[TBL] [Abstract][Full Text] [Related]
11. How Does Stronger Protection of Intellectual Property Rights Affect National Pharmaceutical Expenditure? An Analysis of OECD Countries.
Jung Y; Kwon S
Int J Health Serv; 2018 Oct; 48(4):685-701. PubMed ID: 29978727
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical expenditure, total health-care expenditure and GDP.
Clemente J; Marcuello C; Montañés A
Health Econ; 2008 Oct; 17(10):1187-206. PubMed ID: 18050150
[TBL] [Abstract][Full Text] [Related]
13. Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries.
Elek P; Takács E; Merész G; Kaló Z
Health Policy Plan; 2017 Apr; 32(3):349-358. PubMed ID: 27697777
[TBL] [Abstract][Full Text] [Related]
14. Health care expenditures and GDP in Latin American and OECD countries: a comparison using a panel cointegration approach.
Rodríguez AF; Nieves Valdés M
Int J Health Econ Manag; 2019 Jun; 19(2):115-153. PubMed ID: 30267372
[TBL] [Abstract][Full Text] [Related]
15. Socio-economic factors and health care system characteristics related to cancer survival in the elderly. A population-based analysis in 16 European countries (ELDCARE project).
Quaglia A; Vercelli M; Lillini R; Mugno E; Coebergh JW; Quinn M; Martinez-Garcia C; Capocaccia R; Micheli A;
Crit Rev Oncol Hematol; 2005 May; 54(2):117-28. PubMed ID: 15843094
[TBL] [Abstract][Full Text] [Related]
16. The European challenges of funding orphan medicinal products.
Szegedi M; Zelei T; Arickx F; Bucsics A; Cohn-Zanchetta E; Fürst J; Kamusheva M; Kawalec P; Petrova G; Slaby J; Stawowczyk E; Vocelka M; Zechmeister-Koss I; Kaló Z; Molnár MJ
Orphanet J Rare Dis; 2018 Nov; 13(1):184. PubMed ID: 30396361
[TBL] [Abstract][Full Text] [Related]
17. Unit root properties of OECD health care expenditure and GDP data.
MacDonald G; Hopkins S
Health Econ; 2002 Jun; 11(4):371-6. PubMed ID: 12007167
[TBL] [Abstract][Full Text] [Related]
18. An econometric analysis of health care expenditure: a cross-section study of the OECD countries.
Gerdtham UG; Søgaard J; Andersson F; Jönsson B
J Health Econ; 1992 May; 11(1):63-84. PubMed ID: 10119757
[TBL] [Abstract][Full Text] [Related]
19. Analysis and implications of the determinants of healthcare expenditure in African countries.
Okunade AA
Health Care Manag Sci; 2005 Nov; 8(4):267-76. PubMed ID: 16379410
[TBL] [Abstract][Full Text] [Related]
20. Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries.
Kadkhodamanesh A; Varahrami V; Zarei L; Peiravian F; Hadidi M; Yousefi N
J Pharm Policy Pract; 2021 Oct; 14(1):82. PubMed ID: 34641978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
